DNA testing in the United States dates to the mid-1980s, when forensic laboratories and medical genetics clinics began applying techniques that could read variations in a person’s genetic code. The first high-profile forensic use came in 1987, and within just a few years, DNA evidence was being introduced in courtrooms, hospitals, and immigration offices across the country. What started as a slow, labor-intensive laboratory method has since branched into criminal justice, prenatal care, consumer ancestry kits, mass disaster identification, and more, each application arriving on its own timeline and raising its own set of questions.
The First Forensic DNA Cases
The underlying science originated in England, where geneticist Alec Jeffreys developed “DNA fingerprinting” at the University of Leicester in 1984. American laboratories took notice quickly. In 1987, a Florida court admitted DNA evidence to help convict a rapist, marking the first time a U.S. criminal case relied on genetic identification. That same year, a private lab called Lifecodes Corporation performed forensic DNA analyses in several cases, and the FBI began exploring how to standardize the technique for law enforcement use nationwide.
These early tests used a method called restriction fragment length polymorphism, or RFLP. The process required relatively large, high-quality samples of biological material and could take weeks to produce results. Despite those limitations, RFLP was powerful enough to distinguish one person’s DNA from another’s with high confidence, and it quickly became the gold standard in forensic labs through the late 1980s and into the 1990s.
How the Technology Evolved
RFLP dominated forensic DNA work until the mid-1990s, when a less labor-intensive approach based on the polymerase chain reaction, known as PCR, became available. PCR-based short tandem repeat (STR) analysis could work with much smaller or more degraded samples, and it delivered results faster.1PubMed. Recovery and STR amplification of DNA from RFLP membranes That shift was transformative. Crime scene investigators no longer needed a visible bloodstain or a large tissue sample. A few skin cells on a doorknob or a tiny smear on a cigarette butt could now yield a usable profile.
The FBI launched its Combined DNA Index System, known as CODIS, in 1998 to store and compare STR profiles from convicted offenders, crime scenes, and missing persons across the country. CODIS gave law enforcement the ability to link crimes committed in different states by comparing DNA profiles against a national database. By the early 2000s, all 50 states had enacted laws requiring DNA collection from certain categories of convicted offenders, and many later expanded those requirements to include arrestees.
Medical and Prenatal Diagnostics
Forensic work grabbed the headlines, but DNA testing entered American medicine on a parallel track. By the late 1980s, clinical laboratories were already offering molecular genetic diagnoses for inherited conditions including Duchenne and Becker muscular dystrophy, myotonic dystrophy, Huntington’s disease, and cystic fibrosis.2British Medical Journal. Molecular genetics in clinical practice: evolution of a DNA diagnostic service These early clinical tests typically looked for known mutations within a single gene, helping families understand whether they carried a specific hereditary condition or whether an unborn child was affected.
Prenatal testing took a major step forward with the introduction of non-invasive prenatal testing, or NIPT, which analyzes fragments of fetal DNA circulating in the mother’s blood. By the early 2010s, American physicians were beginning to adopt the technology. A survey found that about a third of responding physicians had already used NIPT, and the vast majority predicted they would offer it to both high-risk and average-risk patients within a year.3PubMed. Non-invasive prenatal testing with cell-free DNA: US physician attitudes toward implementation in clinical practice NIPT can screen for chromosomal conditions like Down syndrome as early as ten weeks into a pregnancy, without the miscarriage risk associated with amniocentesis.
Beyond prenatal screening, the broader trajectory of clinical DNA testing has moved from testing one gene at a time to sequencing entire exomes and then entire genomes. Rapid drops in sequencing costs over the past decade and a half turned whole-genome sequencing from a rare research tool into something with broad clinical applications, used for diagnosing rare diseases, guiding cancer treatment, and identifying pharmacogenomic factors that affect how a patient metabolizes certain drugs.4American Physiological Society (Physiological Genomics). Genome sequencing in the clinic: the past, present, and future of genomic medicine
DNA in Immigration Cases
One of the lesser-known early applications of DNA testing in the United States was verifying biological relationships for immigration purposes. DNA testing for identity or relationship verification in visa and asylum petitions began in the 1980s, making it one of the earliest non-forensic uses of the technology in the country.5PubMed Central. Framing the utility and potential pitfalls of relationship and identity DNA testing across United States immigration contexts When applicants could not produce sufficient documentary evidence of a claimed family relationship, a DNA test could confirm or rule out a biological connection.
The practice raises questions that go beyond science. Family structures around the world do not always match the biological parent-child model that a DNA test is designed to confirm. Adoptive relationships, step-parenting, and extended kinship networks are common in many cultures, and a DNA test that finds no biological link between a petitioner and a claimed relative can undermine a genuine family bond. Scholars examining DNA testing in immigration cases across the United States and Europe have pointed out that these tests tend to reduce the meaning of “family” to a narrow biological definition, sometimes at the expense of people whose family ties are real but not genetic.6Science, Technology, & Human Values. DNA Testing for Family Reunification and the Limits of Biological Truth
Wrongful Convictions and the Power of Re-Testing
If early forensic DNA testing helped put people in prison, it also started getting the wrong people out. The Innocence Project, founded in 1992 by Barry Scheck and Peter Neufeld, pioneered the use of post-conviction DNA testing to exonerate individuals who had been wrongly convicted. By the time researchers analyzed 194 U.S. DNA exonerations representing 171 separate criminal events, the data revealed patterns in the types of evidence and testing methods that freed wrongfully convicted people.7PubMed. The genetics of innocence: analysis of 194 U.S. DNA exonerations
Many of these wrongful convictions had relied on eyewitness misidentification, flawed forensic methods like hair microscopy, or coerced confessions. When preserved biological evidence from the original crime scene was re-tested with newer DNA methods, the results often excluded the convicted person entirely and sometimes pointed to the actual perpetrator. The exoneration movement reshaped how courts, prosecutors, and the public thought about the reliability of pre-DNA forensic evidence, and it drove legislative reforms in many states to guarantee access to post-conviction DNA testing.
Identifying Victims of Mass Disasters
The September 11, 2001 attacks on the World Trade Center pushed forensic DNA science into territory it had never faced. The extreme thermal and physical conditions at the site left remains so fragmented and degraded that traditional identification methods were inadequate for most victims. DNA became the primary tool, and the effort ultimately identified 1,594 of the 2,749 victims through genetic testing.8PubMed. DNA identifications after the 9/11 World Trade Center attack
The scale of the disaster forced scientists to create new procedures or heavily modify existing forensic protocols. While other identification methods like dental records and fingerprints played a role early on, the degree of body fragmentation meant that DNA eventually became the singular identification method relied upon for the majority of identifications.9PubMed. Victim identification from the September 11, 2001 attack on the World Trade Center: Past trends and future projections The lessons learned during that effort shaped protocols for mass disaster identification worldwide, and the work continues. As technology improves, investigators periodically re-examine unidentified remains using newer, more sensitive techniques, and additional identifications have been made years and even decades after the attacks.
Consumer DNA Testing and the FDA
For most of its history, DNA testing required a doctor’s order, a law enforcement request, or a court directive. That changed in the mid-2000s when companies like 23andMe and Ancestry began offering direct-to-consumer kits that anyone could order online. You would spit into a tube, mail it to a lab, and receive results about your ancestral origins, genetic health risks, or carrier status for certain inherited conditions.
The consumer market grew rapidly, but it did not go unregulated for long. In November 2013, the FDA sent a warning letter to 23andMe ordering the company to stop marketing its Personal Genome Service until it received marketing authorization. The FDA classified the service as a medical device because the health-related results could influence medical decisions, and selling an unauthorized medical device was not something the agency was willing to overlook.10PubMed Central. Reflections on the US FDA’s Warning on Direct-to-Consumer Genetic Testing 23andMe temporarily halted its health reports, then gradually re-introduced them after obtaining FDA authorization for specific tests over the following years.
Today, consumer testing companies have built databases containing genetic profiles from tens of millions of people. The ancestry side of the business remains popular, though genetic counselors have noted that ancestry results can be misunderstood. The percentages reported (“42% Irish,” “18% West African”) are statistical estimates based on reference populations, not definitive markers of identity or heritage, and they can shift as companies update their reference panels.
Genetic Genealogy and Cold Cases
The massive consumer DNA databases created an investigative opportunity that nobody in law enforcement originally anticipated. On April 24, 2018, police arrested a suspect in California’s notorious Golden State Killer cases after decades of failed investigation. Detectives had uploaded a DNA profile from crime scene evidence to GEDmatch, a free online genetic genealogy database populated by people researching their family trees. The upload returned partial matches to distant relatives of the suspect, and traditional genealogical research narrowed the field until investigators identified a single individual.11PubMed Central. Should police have access to genetic genealogy databases? Capturing the Golden State Killer and other criminals using a controversial new forensic technique
The arrest electrified both law enforcement and privacy advocates. Investigative genetic genealogy, as the technique came to be called, has since been used to solve hundreds of cold cases across the country. But the method relies on databases that people contributed to voluntarily, usually to learn about their own ancestry, not to help solve crimes. After the Golden State Killer arrest, GEDmatch changed its terms of service so that users had to explicitly opt in to law enforcement searches. The Department of Justice also issued interim guidelines in 2019 requiring federal investigators to exhaust traditional methods, including CODIS, before turning to genetic genealogy databases.
Privacy Protections Under Federal Law
As DNA testing spread into medicine, employment, and insurance, lawmakers recognized the potential for genetic discrimination. If your DNA test reveals a predisposition to a serious disease, could an employer use that information against you? Could an insurer deny coverage? Congress addressed these concerns by passing the Genetic Information Nondiscrimination Act of 2008, commonly known as GINA. The law prohibits health insurers from using genetic information to make coverage or premium decisions and bars employers from using it in hiring, firing, or promotion.12PubMed Central. The Genetic Information Nondiscrimination Act (GINA): public policy and medical practice in the age of personalized medicine
GINA was a significant step, but it has gaps. The law does not cover life insurance, disability insurance, or long-term care insurance. That means a life insurer can, in principle, ask about genetic test results and use them to set premiums or deny a policy. Some states have passed their own laws to fill in portions of this gap, but coverage varies widely. The law also does not address newer scenarios like law enforcement use of genetic databases or the privacy implications of sharing your DNA with a consumer testing company.13PubMed. The Genetic Information Nondiscrimination Act: why your personal genetics are still vulnerable to discrimination If you are considering a DNA test of any kind, understanding what GINA does and does not protect is worth your time.
DNA Testing and Native American Communities
Ancestry DNA tests frequently report percentages of “Native American” or “Indigenous American” heritage, and some individuals have used those results to claim a connection to tribal communities. This is a sore point for many Native American nations. Tribal membership in the United States is determined by tribal governments exercising their sovereign authority, not by a genetic test. Tribes set their own enrollment criteria, which often emphasize documented lineage through tribal rolls and demonstrated community participation rather than DNA markers.14Genetics in Medicine. Constructing identities: the implications of DTC ancestry testing for tribal communities
The disconnect between what a commercial test reports and what tribal membership actually requires is significant. A person might receive ancestry results showing a percentage of Indigenous American genetic markers yet have no family history, cultural ties, or community connections to any specific tribe. Native scholars have raised pointed questions about what non-Native people are trying to legitimize with the concept of “Native American DNA” and have pushed back against the idea that a genetic test can substitute for lived identity and community belonging.15PubMed Central. “We Don’t Need a Swab in Our Mouth to Prove Who We Are”: Identity, Resistance, and Adaptation of Genetic Ancestry Testing among Native American Communities For many Indigenous communities, whose histories include traumatic interactions with colonial powers and Western science, DNA testing represents yet another external framework being imposed on their self-determination.
Beyond Humans: DNA Testing in Agriculture and Animal Breeding
The spread of DNA testing was never limited to people. The animal breeding world adopted molecular genetic tests on a timeline that closely mirrors the forensic story. Horse breed registries, for example, had long relied on blood-typing to verify parentage. In the mid-1990s, those registries began transitioning to microsatellite DNA markers, which proved more reliable and could work with simple hair samples rather than blood draws. After about five years of experience, microsatellite-based parentage testing had demonstrated that DNA met the needs of horse owners and breed registries alike.16Livestock Production Science. Historical development and application of molecular genetic tests for horse identification and parentage control
Cattle, dogs, and other domesticated animals followed similar paths. Today, DNA testing is routine in livestock management for verifying parentage, screening for genetic diseases, and selecting for desirable traits. The pet DNA testing market has also boomed, with companies offering breed identification and health screening for dogs and cats. The underlying technology is the same STR and single-nucleotide polymorphism analysis used in human testing, scaled and calibrated for different species’ genomes.